In continuation of our group’s previous work on immune cell infiltration in BCC and cSCC [35], the aim of this study was to make a quantitative analysis of the inhibitory and activating immune checkpoint pathways PD-1/PD-L1 and CD28/CD86 in both BCC and cSCC. This evidence concerns the gene CD28 and skin basal cell carcinoma.